Guillain-Barré syndrome associated with Campylobacter jejuni infection in England, 2000-2001

Clinical Infectious Diseases

Volumn 37, Issue 2, 2003, Pages 307-310

  Tam, Clarence C ^a,b   Rodrigues, Laura C ^b   O'Brien, Sarah J ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY BURDEN; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; INFECTION RISK; INTESTINE INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SYMPTOMATOLOGY; UNITED KINGDOM; COHORT ANALYSIS; SWEDEN;

CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; COHORT STUDIES; ENGLAND; GUILLAIN-BARRE SYNDROME; HUMANS; SWEDEN;

EID: 0041766677     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/375845     Document Type: Article

References (22)

1. Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 1997; 176:S92-8.
2. Kaldor J, Speed BR. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br Med J (Clin Res Ed) 1984; 288:1867-70.
3. Jacobs BC, Rothbarth PH, van der Meche FG, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 1998; 51:1110-1115.
4. Mishu B, Ilyas AA, Koski CL, et al. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med 1993; 118:947-53.
5. Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995; 333:1374-9.
6. Kuroki S, Saida T, Nukina M, et al. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues. Ann Neurol 1993; 33:243-7.
7. Lastovica AJ, Goddard EA, Argent AC. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains. J Infect Dis 1997; 176:S139-43.
8. Hadden RD, Gregson NA. Guillain-Barré syndrome and Campylobacter jejuni infection. Symp Ser Soc Appl Microbiol 2001; 30:145S-54S.
9. Havelaar AH, de Wit MA, van Koningsveld R, van Kempen E. Health burden in The Netherlands due to infection with thermophilic Campylobacter spp. Epidemiol Infect 2000; 125:505-22.
10. Allos BM. Association between Campylobacter infection and Guillain-Barré syndrome. J Infect Dis 1997; 176:S125-S7.
11. Allos BM. Association between Campylobacter infection and Guillain-Barré syndrome. J Infect Dis 1997; 176:S125-S7. Cawthraw SA, Feldman RA, Sayers AR, Newell DG. Long-term antibody responses following human infection with Campylobacter jejuni. Clin Exp Immunol 2002; 130:101-6.
12. Strid MA, Engberg J, Larsen LB, Begtrup K, Molbak K, Krogfelt KA. Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients. Clin Diagn Lab Immunol 2001; 8:314-19.
13. McCarthy N, Andersson Y, Jormanainen V, Gustavsson O, Giesecke J. The risk of Guillain-Barré syndrome following infection with Campylobacter jejuni. Epidemiol Infect 1999; 122:15-17.
14. McCarthy N, Giesecke J. Incidence of Guillain-Barreé syndrome following infection with Campylobacter jejuni. Am J Epidemiol 2001; 153:610-14.
15. Food Standards Agency. A report of the study of infectious intestinal disease in England. London: The Stationery Office, 2000.
16. UK Department of Health. Hospital Episodes Statistics. Available at: http://www.doh.gov.uk/hes/index.html. Accessed 8 July 2003.
17. Campylobacter sentinel surveillance scheme. Commun Dis Rep CDR Wkly [serial online]. 2001; 11:23. Available at: http://www.phls.org.uk/publications/cdr/pages/back_issues.html. Accessed 8 July 2003.
18. Tam CC, Rodrigues LC, O'Brien SJ. The study of infectious intestinal disease in England: What risk factors for presentation to general practice tell us about potential for selection bias in casecontrol studies of reported cases of diarrhea. Int J Epidemiol (in press).
19. Kuroki S, Haruta T, Yoshioka M, Kobayashi Y, Nukina M, Nakanishi H. Guillain-Barré syndrome associated with Campylobacter infection. Pediatr Infect Dis J 1991; 10:149-51.
20. Jacobs BC, van Doorn PA, Schmitz PI, et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann Neurol 1996; 40:181-7.
21. Rees JH, Gregson NA, Hughes RA. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995; 38:809-16.
22. Buzby JC, Allos BM, Roberts T. The economic burden of Campylobacter-associated Guillain-Barré syndrome. J Infect Dis 1997; 176:S192-7.